Medisave Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer · Lahore · Pakistan
Lahore-based pharmaceutical manufacturer established to produce medicines for local and international markets.
Medisave Pharmaceuticals products in Pakistan
Medisave Pharmaceuticals has 115 medicine presentations registered in Pakistan under 55 brands, covering 53 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Cexzone (Ceftriaxone), Ciprozan (Ciprofloxacin), Diclosave (Diclofenac) and Duloxisave (Duloxetine). 115 products have an official DRAP price on MedInfoBase. See all 55 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer
- Address
- 501-A, Block-E, Saman Berg, Johar Town, Lahore, Pakistan
- Website
- medisave.com.pk ↗
- Phone
- +92 42 35176016
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 75%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Medisave Pharmaceuticals is priced against the market
101 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| No matching products. | ||||||||
All 55 Medisave Pharmaceuticals brands in Pakistan
- ABT-ZOLD Zoledronic acid · 5 mg/100 mL infusion
- Alusave Aluminium hydroxide + Magnesium hydroxide + Oxethazaine · 291 mg + 98 mg + 10 mg/5 mL suspension
- Amisave 250/ml Amikacin · 250 mg injection
- Anata Metronidazole · 200 mg tablet, 400 mg tablet, 500 mg infusion
- Ascomed Ascorbic acid · 500 mg tablet
- Ceftisav Cefotaxime · 1000 mg injection, 250 mg injection, 500 mg injection
- Cefusave Cefuroxime · 1.5 g injection, 750 mg injection
- Cesave Cefixime · 100 mg/5 mL suspension, 400 mg capsule
- Cesave-200mg Cefixime · 200 mg/5 mL suspension
- Cexzone Ceftriaxone · 1000 mg injection, 250 mg injection, 500 mg injection
- Ciprozan Ciprofloxacin · 200 mg/100 mL infusion, 250 mg tablet, 250 mg/5 mL suspension
- Conosave Fluconazole · 150 mg capsule
- Diclosave Diclofenac · 50 mg tablet, 75 mg/3 mL injection
- Diclosave SR Diclofenac · 100 mg tablet
- Dinsave Loratadine · 10 mg tablet, 5 mg/5 mL syrup
- Duloxisave Duloxetine · 20 mg capsule, 30 mg capsule, 60 mg tablet
- Falcim Artemether + Lumefantrine, Artemether · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet, 80 mg + 480 mg tablet
- Falcim 80 Artemether + Lumefantrine · 80 mg + 480 mg tablet
- Falcim dry Artemether + Lumefantrine · 15 mg + 90 mg/5 mL suspension
- Gabisave Pregabalin · 150 mg capsule, 50 mg capsule, 75 mg capsule
- Henk Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
- Itrasave Itraconazole · 100 mg capsule
- Iversav Ivermectin · 6 mg tablet
- Jocin Fluoxetine · 20 mg tablet
- Kalasave Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Lactosav Lactulose · 3.35 g/10 mL syrup
- Linzrao Linezolid · 100 mg/5 mL suspension, 200 mg/100 mL infusion, 600 mg tablet
- Lopisav Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- Maczin Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 250 mg capsule
- Medac Levofloxacin · 250 mg tablet, 500 mg tablet, 500 mg/100 mL infusion
- Medica Lidocaine · 2 % injection
- Medikast Montelukast · 10 mg tablet, 5 mg tablet
- Medistil Water for Injection · 10 mL injection, 5 mL injection
- Medizink Zinc · 10 mg/5 mL suspension
- Mepzan Omeprazole, Esomeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
- Moxbec Moxifloxacin · 400 mg infusion, 400 mg tablet
- Nephsav Norepinephrine · 4 mg/4 mL injection
- Neudime Ceftazidime · 1000 mg injection, 250 mg injection, 500 mg injection
- O-save Olanzapine · 10 mg tablet, 5 mg tablet
- Ondasave Ondansetron · 4 mg/5 mL solution, 8 mg tablet
- Penesav Meropenem · 1 g injection, 500 mg injection
- Quinsav Chloroquine · 250 mg tablet
- Ribaxol Ribavirin · 400 mg tablet, 600 mg tablet
- Rispolet Risperidone · 1 mg tablet, 2 mg tablet
- Rosun Rosuvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
- Savgrel Clopidogrel · 75 mg tablet
- Seltasav Oseltamivir · 75 mg capsule
- Solara Ceftriaxone · 1 g injection
- Stigsav Neostigmine, Neostigmine methylsulfate · 2.5 mg injection, 2.5 mg/mL injection
- Telsun 80 Telmisartan + Amlodipine · 80 mg + 10 mg tablet
- Tericim Levetiracetam · 100 mg/mL solution, 250 mg tablet, 500 mg tablet
- Trisave Tranexamic acid · 250 mg capsule, 250 mg/5 mL injection, 500 mg injection
- Urifast Nitrofurantoin · 100 mg tablet
- Vancosave Vancomycin · 500 mg injection
- Virsave Tenofovir disoproxil · 300 mg tablet
Medisave Pharmaceuticals: common questions
How many products does Medisave Pharmaceuticals have in Pakistan?
Medisave Pharmaceuticals has 115 registered medicine presentations in Pakistan, sold under 55 brands and covering 53 generic medicines.
What are the main brands of Medisave Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Cexzone (Ceftriaxone), Ciprozan (Ciprofloxacin), Diclosave (Diclofenac), Duloxisave (Duloxetine) and Falcim (Artemether + Lumefantrine, Artemether). This is not a sales ranking.
Which therapy areas does Medisave Pharmaceuticals cover?
The most products are in Anti-infectives (64), CNS & mental health (16), Gastrointestinal & hepatology (8), Pain & musculoskeletal (5) and Cardiovascular (5).
Where can I see Medisave Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.